It has been demonstrated that mutations in the SLC9A6 gene can result in a syndrome characterized by mental retardation, tau deposition and neurodevelopmental delay, as well as cognitive impairment [83, 84]. The gene discussed is MAPT; the disease is Cognitive impairment.